It was found that the partially puriˆed b-ketoacyl-ACP synthase of Bacillus insolitus did not require the addition of FabD (malonyl-CoA:ACP transacylase, MAT) for the activity assay. This study therefore examined the necessity of FabD protein for in vitro branchedchain fatty acid (BCFA) biosynthesis by crude fatty acid synthetases (FAS) of Bacilli. To discover the involvement of FabD in the BCFA biosynthesis, the protein was removed from the crude FAS by immunoprecipitation. The His-tag fusion protein FabD of Bacillus subtilis was expressed in Escherichia coli and used for the preparation of antibody. The rabbit antibody raised against the expressed fusion protein speciˆcally recognized the FabD in the crude FAS of B. subtilis. Evaluation of the e‹cacy of the immunoprecipitation showed that a trace of FabD protein was present in the antibody-treated crude FAS. However, this complete removal of FabD from the crude FAS did not abolish its BCFA biosynthesis, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for a-keto-b-methylvalerate primer. Furthermore, the FabD concentration did not necessarily correlate with the MAT speciˆc activity in the enzyme fractions, suggesting the presence of another enzyme source of MAT activity. This study, therefore, suggests that FabD is not the sole enzyme source of MAT for in vitro BCFA biosynthesis, and implies the existence of a functional connection between fatty acid biosynthesis and another metabolic pathway.
It was found that the partially puriˆed b-ketoacyl-ACP synthase of Bacillus insolitus did not require the addition of FabD (malonyl-CoA:ACP transacylase, MAT) for the activity assay. This study therefore examined the necessity of FabD protein for in vitro branchedchain fatty acid (BCFA) biosynthesis by crude fatty acid synthetases (FAS) of Bacilli. To discover the involvement of FabD in the BCFA biosynthesis, the protein was removed from the crude FAS by immunoprecipitation. The His-tag fusion protein FabD of Bacillus subtilis was expressed in Escherichia coli and used for the preparation of antibody. The rabbit antibody raised against the expressed fusion protein speciˆcally recognized the FabD in the crude FAS of B. subtilis. Evaluation of the e‹cacy of the immunoprecipitation showed that a trace of FabD protein was present in the antibody-treated crude FAS. However, this complete removal of FabD from the crude FAS did not abolish its BCFA biosynthesis, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for a-keto-b-methylvalerate primer. Furthermore, the FabD concentration did not necessarily correlate with the MAT speciˆc activity in the enzyme fractions, suggesting the presence of another enzyme source of MAT activity. This study, therefore, suggests that FabD is not the sole enzyme source of MAT for in vitro BCFA biosynthesis, and implies the existence of a functional connection between fatty acid biosynthesis and another metabolic pathway.
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Bacillus; malonyl-CoA; ACP Fatty acids are the most important component of bacterial membrane lipids. The chemical structure of fatty acids occurring in bacteria is classiˆed largely into two types: straight-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) of the isoand anteiso-series. The SCFA synthesis represented by the E. coli system has been studied in detail, and the biosynthesis pathway consists of a set of individual enzyme proteins (type II) that function in concert to produce a variety of fatty acids. 1, 2) Although the lower activity of BCFA biosynthesis in the cell-free system of Bacilli has severely impeded the eŠorts to establish a detailed synthetic mechanism by using the individually isolated enzymes, the available evidence strongly supports the view that BCFAs in bacteria are synthesized by a mechanism very similar to that of SCFA synthesis operating in E. coli.
3)
The diŠerence between SCFA and BCFA biosynthesis thus appeared to lie in the precursor speciˆcity of the initiation step: the substrate speciˆcity of acylCoA:ACP transacylase (step B in Fig. 1 ) 4) or theˆrst step condensing enzyme of b-ketoacyl-ACP synthase III (KAS III) FabH (steps C, D, and E in Fig. 1 ). It has actually been shown by using a His-tag fusion protein of FabH that the Bacillus FabH (bFabH) is a determining factor in BCFA biosynthesis. 5) There are at least two FabH (KAS III) like protein and one FabB W F (KAS IW II) homologue encoded by the B. subtilis genome.
The initiation of the condensing reaction (steps C, D, and E in Fig. 1 ) usually requires the presence of malonyl-CoA:ACP transacylase (MAT) FabD that catalyzes the conversion of malonyl-CoA to malonyl ACP (step A in Fig. 1) . It was also shown that the B. subtilis fabD gene complemented the MAT deˆciency of an E. coli mutant.
6) However, we found in the course of enzyme puriˆcation work that partially puriˆed native KAS from B. insolitus did not necessarily require the addition of FabD for the activity assay. Thus this study clariˆed the requirement of FabD for BCFA biosynthesis in vitro and discussed the necessity of FabD for the condensation reaction in Bacilli. 
Materials and Methods

Materials. [
14 C]-Malonyl-CoA and [ 14 C]-isoleucine were purchased from Muromachi Chemicals Co. [ 14 C]-isoleucine was converted into the corresponding a-ketoacid using L-amino acid oxidase and catalase (both from Sigma-Aldrich Japan.) as described previously. 7) Malonyl-CoA and acyl carrier protein from E. coli were from Sigma-Aldrich Japan Co. Other chemicals used were all the highest grade and were obtained from the domestic suppliers.
Construction of expression vectors and puriˆca-tion of His-tag protein. The malonyl-CoA:ACP transacylase gene (fabD) of B. subtilis was ampliˆed with a genomic DNA as PCR template. The forward and reverse primers designed based on the FabD gene sequence in the DNA database``SubtiList'' respectively created a restriction site for NdeI and BamHI at the 5? terminus, and consisted of 5?-CAT-GCATATGATTGCATTTTTATTCCCGG and 5?-TTTAGGATCCAGCATTATCATTCTCCTCCT. The PCR products wereˆrst ligated into pCRII (Invitrogen) by use of a TOPO-TA cloning kit (Invitrogen), and used to transform TOPO10-competent E. coli cells. A plasmid was isolated and digested with NdeI and BamHI. The released insert DNA fragment were separated by agarose gel electrophoresis, and ligated into pET-15b digested previously with NdeI and BamHI. The ligation mixture was used to transform a BL21(DE3) competent cell strain. The plasmid harboring the fabD gene was isolated, and sequenced to verify the absence of PCR artifacts. Protein expression was induced according to the manufacture's instruction manual. The His-tag fusion protein was puriˆed by use of His Trap chelating a‹nity column (Amersham Pharmacia Biotech).
Preparation of short-chain acyl-CoA. The branched short-chain fatty acids were converted into their thioesters as described previously. 8) Brie‰y, the shortchain fatty acid (5 mmol) was reacted with carboxydiimidazole (6 mmol) in 0.2 ml of tetrahydrofuran to give a rise to 1-acylimidazole. After 30 min of reaction at room temperature, the solvent was evaporated oŠ, and the reaction product was dissolved in 0.2 ml tetrahydrofuran-H2O (2:1 by vol.). The solution was allowed to react with 5 mmol of CoASH in 0.5 ml of tetrahydrofuran-H2O (2:1 by vol.). The reaction was continued for 4 hours at room temperature with a nitrogen atmosphere. Tetrahydrofuran was evaporated oŠ, and the residual aqueous solution was acidiˆed to pH 3-4 by the addition of Dowex 50 (H ＋ ). Dowex 50 was removed byˆltration, and thê ltrate was extracted with diethyl ether (0.5 ml×3 times) to remove unreacted fatty acid. The concentration of acyl-CoA thioester was measured by DTNB (5,5?-dithiobis-2-nitrobenzoic acid) method as described previously.
9) Acyl-CoA thioester synthesized by this method was usually over 90z pure on the basis of free and esteriˆed SH assays.
9)
Bacterial strain and cell culture. The strains used for the preparation of crude enzyme were Bacillus subtilis (ATCC23857) and Bacillus insolitus (ATCC-23299). Cells were suspended in 15z glycerol and stored at -709 C. The culture medium for B. subtilis contained: glucose, 10 g; yeast extract, 1 g; Bacto peptone, 1 g; K2HPO4, 1.5 g; NH4H2PO4, 0.5 g; MgSO 4 ･7H 2 O, 0.1 g; ZnSO 4 ･7H 2 O, 10 mg; CuSO 4 ･ 5H2O, 0.5 mg; MnCl2･4H2O, 4.5 mg; and FeSO4･ 7H2O, 10 mg, in 1 liter of distilled water.
10) The culture medium for B. insolitus was Soybean-CaseinDigest broth supplied by Nissui Pharmaceutical Co. (Tokyo, Japan). The indicated concentration of the medium was peptone 17 g, soybean-peptone 3 g, NaCl 5 g, glucose 2.5 g, and K2HPO4 2.5 g per litter.
The seed culture in 20 ml was inoculated with the stock cells, and was incubated 7 hours at 309 C for B. subtilis, and 16 hours at 209 C for B. insolitus. One litter of medium was inoculated with 10 to 20 ml of seed culture, and cells were harvested at the late exponential growth phase by centrifugation. The yield of cells was usually in the range of 5-6 g wet weight W l culture medium.
Preparation of crude enzyme. A typical procedure for the preparation of crude enzyme was as follows. Pelleted cells were suspended in 3 vol. of 10 mM phosphate buŠer (pH 7.0) containing 2 mM 2-mercaptoethanol and 10z glycerol, and were sonicated with an ultrasonic generator (Nihon Seiki Seisakusho Co., Tokyo) for 3×3 min with 1-min cooling intervals. The irradiated cell suspension was centrifuged for 28,000×G for 30 min, and the supernatant was again centrifuged at 156,000×G for 2 hours. To the supernatant was added streptomycin sulfate to make its concentration equivalent to protein in the extract. The precipitate formed was then removed by centrifugation at 28,000×G for 20 min. The supernatant obtained after streptomycin treatment was mixed with 1W 10 vol. of 1 M phosphate buŠer (pH 7.0) and with (NH4)2SO4 to 60z saturation. The precipitate formed was collected by centrifugation, and dissolved in a minimal volume of 10 mM phosphate buŠer (pH 7.0). Theˆnal protein concentration was usually from 20 to 60 mg W ml.
Puriˆcation of the condensing enzyme. Puriˆca-tion of the condensing enzyme was done by a use of fast protein liquid chromatography (FPLC) system (Amersham-Pharmacia Biotech) or perfusion chromatography system (Perceptive Biosystems). The crude enzyme (0-60z (NH4)2SO4 precipitate was diluted 5 to 9 times with the starting buŠer containing 20 mM histidine-HCl (pH 5.5), 2 mM dithiothreitol (DTT) and 10z glycerol, and was put on a Mono Q HR 10 W 10 column (Amersham-Pharmacia Biotech) which had previously been equilibrated with the same buŠer. The column was washed with 3 ml of starting buŠer and was eluted with a linear gradient of 0-0.65 M NaCl in 27 ml of the buŠer with the ‰ow rate of 1.5 ml W min.
The fractions containing the condensing enzyme were mixed with 3 M (NH4)2SO4 to make 1.8 M, and put on a reversed-phase column PE W M (4.6 mm ID× 100 mm, Perceptive Biosystem) equilibrated with 10 mM phosphate buŠer (pH 7.0) containing 1.8 M (NH4)2SO4, 2 mM DTT and 10z glycerol. The sample was eluted with a negative linear gradient of 1.8-0 M (NH 4 ) 2 SO 4 in a 15 ml of eluent. The active enzyme fractions were combined and concentrated by ultraˆltration (Centricon 30 or 50, Amicon Inc.) to 0.2 ml, and put onto Superose 12 HR 10 W 30 column (Amersham-Pharmacia Biotech) that had been previously equilibrated with the elution buŠer containing 50 mM potassium phosphate (pH 6.0), 0.15 M NaCl, 2 mM DTT, and 10z glycerol. The sample was eluted with a ‰ow rate of 0.2 ml W min.
Condensing enzyme assay. [
14 C]-CO2 liberated by the action of the condensing enzyme from [1,3- 14 C]-malonyl-CoA was collected in NaOH, and used for measurement of radioactivity.
11) The reaction mixture contained 50 mM triethanolamine (pH 7.5), 1 mM DTT, 2.5 mM ACP, 40 mM [1,3-14 C]-malonylCoA (37 kBq W mmol) in 0.5 ml. The reaction was incubated at 309 C for 30 min, and stopped by addition of 0.2 ml 5z HClO 4 . The [
14 C]-CO 2 produced was collected into 0.2 ml of 2 N NaOH for 60 min in a closed reaction tube, and was counted with 8 ml of scintillation ‰uid (ACS II).
Fatty acid synthetase (FAS) activity. Fatty acid synthetase (FAS) activity was measured by incorporation of [U-
14 C]-a-keto-b-methylvalerate (KMV) (740 kBq W mmol) or [1,3- 14 C]-malonyl-CoA (37 kBq W mmol) into fatty acid. The radiolabeled fatty acid was isolated from the reaction mixture by a solvent extraction procedure. The standard reaction mixture contained, in mM: triethanolamine, 50 (pH 7.5); DTT, 2; thiaminepyrophosphate, 0.5; NADPH, 0.5; malonyl CoA, 0.1; and [U- 14 C]-KMV 0.01, in a total volume of 500 ml. In the case where cold acyl-CoA was the precursor, [U-
14 C]-KMV was replaced with cold acyl-CoA (0.1 mM), and cold malonyl-CoA was replaced with [1,3- 14 C]-malonyl CoA (0.04 mM). The reaction mixture was incubated at 309 C for 30 min. The enzyme reaction was stopped by the addition of 0.025 ml of 6 N HCl, and the acidiˆed reaction mixture was centrifuged at 600×g for 5 min. The supernatant was mixed with 0.35 ml of H2O, 0.5 ml of methanol and 3 ml of CCl4 in a glass-stoppered test tube. The lower layer (CCl 4 ) was washed twice with 2.5 ml of 50z methanol containing 0.05 N HCl. The washed CCl4 layer was evaporated to dryness by ‰ushing with N2, and its radioactivity was counted with a toluene scintillator.
Malonyl-CoA:ACP transacylase (MAT) assay. The MAT activity assay was done essentially as described elsewhere.
12) Brie‰y, the reaction mixture containing 7.5 mM [1, 3- 14 C]-malonyl-CoA (2035 kBq W mmol), 10 mg ACP (23.2 mM), 1 mM DTT, 100 mM imidazole-HCl (pH 7.0), and up to 1 mg of FabD in â nal volume of 50 ml was incubated at 309 C for 5 min. The reaction was stopped with 0.4 ml of 5z perchloric acid, followed by the addition of 370 mg of carrier crude ACP prepared from a B. subtilis homogenate. The precipitate formed was collected bŷ ltration with a 0.2 mm pore size membraneˆlter, and was further washed twice with 0.5 ml of 5z perchloric acid. The malonyl-ACP present in the precipitate was re-dissolved in 0.5 ml 0.1 N NaOH, and counted for its radioactivity.
Preparation of antibody. Antibody against the puriˆed His-tag fusion protein FabD was raised in a male Japanese white rabbit with a mixture of equal volume of Freud's complete adjuvant and 203 mg antigen FabD protein. The animal received the injection twice a week for one month, and was bled after the The expressed protein was puriˆed to homogeneity and separated on a polyacrylamide gel. The assay mixture contained 50 mM triethanolamine (pH 7.5), 2 mM thiaminepyrophosphate, 0.5 mM NADPH, 0.04 mM [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-malonyl-CoA, 0.1 mM acyl-CoA, and 0.5-2 mg of crude FAS in 500 ml. The reaction was done at 309 C for 30 min, and the reaction product of radiolabeled fatty acid was extracted into CCl 4 for measurement of its radioactivity.
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Fatty Acid Biosynthesis in Bacilli enough antibody production was conˆrmed by double immunodiŠusion analysis. 13) Enrichment of IgG was made by (NH4)2SO4 fractionation as follows: the rabbit serum was mixed with an equal volume of 50z (NH 4 ) 2 SO 4 in 50 mM phosphate buŠer (pH 7.0). After 20 min, the precipitate formed was collected by centrifugation (12000×G, 10 min), and washed with 25z (NH4)2SO4 in 50 mM phosphate buŠer (pH 7.0). The washed precipitate was dissolved in 20 mM phosphate buŠer, (pH 7.0) and dialyzed overnight against the same buŠer. The dialyzed solution was centrifuged, and the supernatant was stored at -709 C until needed.
Immunoprecipitation. The crude FAS was mixed with an equal amount of IgG to give theˆnal enzyme concentration of 19.6 mg W ml. Since the crude FAS contained 1.04 mg FabDW mg total protein, theˆnal concentration of FabD in the mixture was 20 mg W ml. The mixture containing 3 mg of enzyme protein was used with or without centrifugation for the BCFA biosynthesis or MAT assay. In the case of control, IgG was replaced by bovine serum albumin to adjust the total protein concentration.
Western blotting. Samples separated on SDS-PAGE were transblotted to nitrocellulose membranes as described elsewhere. The membrane was washed with phosphate-buŠered saline containing Tween 20 (PBS-T): 80 mM Na 2 HPO 4 , 20 mM NaH2PO4, 100 mM NaCl, 0.1z Tween 20, and subsequently incubated in a 10z skim milk blocking solution for 30 min with occasional shaking. The membrane was washed with PBS-T and incubated with primary antibody (anti FabD) for 60 min at room temperature. The un-bound antibody was washed out with several changes of PBS-T. The antiFabD IgG bound to the sample was made visible by ECL Western blotting detection reagent (AmershamPharmacia Biotech). Figure 2 shows the SDS-PAGE of the His-tag fusion protein FabD. The expressed His-tag protein was puriˆed to homogeneity by Ni 2＋ chelate a‹nity chromatography, and thereafter desalted with a PD-10 column (Amersham-Pharmacia Biotech). The estimated molecular mass on SDS-PAGE was 41 kDa, which was slightly higher than the calculated molecular size of 37 kDa. This preparation was used for the condensing enzyme assay and for the preparation of antibody.
Results
In order to choose the bacterial strain for the puriˆcation of the condensing enzyme, weˆrst studied in vitro biosynthesis of fatty acids by the cell-free homogenate of B. subtilis and B. insolitus (Fig. 3) . In contrast to the case of E. coli, the cell-free homogenate of B. subtilis and B. insolitus accepted a variety of acyl-CoA derivatives as a precursor for fatty acid biosynthesis. Acyl-CoAs of chain-lengths C4 to C12 were good precursors for fatty acid biosynthesis by the crude fatty acid synthetase (FAS) of B. subtilis and B. insolitus. On the whole, the crude FAS of B. insolitus showed a rather broad spectrum of precursor speciˆcity, accepting both straight-chain and branched-chain acyl-CoA (BCAC) to an almost comparable extent. The relatively higher biosynthetic activity of B. insolitus was also notable (see the diŠerence in the scale of X-axis). The crude FAS of B. subtilis surprisingly manifested a preference for straight-chain acyl-CoA, except for acetyl-CoA, rather than toward the branched-chain counterpart.
Combination of an ion-exchange column (Mono Q), a hydrophobic column (PE W M), and a gel-ˆltra-tion column (Superose 12), puriˆed the condensing enzyme 5-fold from the cell-free homogenate of B. insolitus. On the course of this puriˆcation, the assay component requirement of the partially puriˆed condensing enzyme was studied (Table 1) . Based on the substrate speciˆcity of the crude FAS, hexanoyl-CoA was the acyl-CoA substrate for the condensing reaction. The reaction unexpectedly did not require the FabD, while was completely dependent on the presence of ACP. Removal of hexanoyl-CoA and DTT respectively lowered the activity to 30.6 and 47.6z of the control value. The incomplete block of the condensation reaction by withdrawal of the substrate hexanoyl-CoA may show that the decarboxylation reaction at the malonyl-ACP binding site partially proceeded even in the absence of acyl-CoAs, but not to the completion of the reaction.
The above observations prompted us to suspect the necessity of the FabD for the condensation reaction and also for the BCFA biosynthesis. There was actually a 5-fold increase in the speciˆc activity of the condensing enzyme with the progress of the puriˆca-tion, even when the assay was done without FabD. Puriˆcation of KAS from B. subtilis encountered di‹culties due to its low activity and instability, as we mentioned in the foregoing section. We therefore prepared the antibodies against FabD, and studied its eŠect on in vitro BCFA biosynthesis by crude FAS of B. subtilis. Figure 4 shows the Western blotting pro-ˆl e of the crude FAS from B. subtilis and B. insolitus. The antibody raised against the His-tag fusion protein FabD recognized essentially a single protein in both crude FASs. The densitometric analysis found that crude FAS from B. subtilis and B. insolitus respectively contained 1.04 mg and 0.37 mg of FabD W mg total protein. The crude FAS from B. insolitus contained the FabD in concentrations from one sixth to one third of B. subtilis, and contrasted with its higher BCFA biosynthetic activity compared with that of B. subtilis. As was expected, the native FabD in the crude synthetase moved slightly faster than the His-tag fusion protein FabD. It is thus now possible to remove only the FabD protein from the crude FAS by immunoprecipitation.
A preliminary experiment on double immunodiŠu-sion found that the equivalence was reached with 0.25 mg anti-FabD IgG against 1 mg of crude FAS. To ensure the complete removal of FabD by the immunoprecipitation method, the concentration course of antibody was studied against the His-tag fusion protein FabD (Fig. 5A) . In this case, theˆnal concentration of His-tag FabD in the reaction mixture was comparable to the following immunoprecipitation experiment. As shown in Fig. 5A , addition of antibody itself had little eŠect on FabD activity. However, removal of the FabD-antibody complex by the centrifugation completely abolished the activity in the supernatant. Based on this experiment, an excess of antibody (1 mg against 1 mg FabD) was used Table 2 . Data are expressed as the percentages of the control activity (non-treaed enzyme). Control activity was 645 nmol W mg for His-tag fusion protein FabD (A) and was 1.89 nmol W mg for crude FAS (B). In analogy to the constructed immunoprecipitation experiment shown in Fig. 5A , the eŠect of antibody on MAT activity of crude FAS was studied (Fig. 5B) . The X-axis shows the amount of antibody added against 1 mg of crude FAS containing 1.04 mg FabD. Thus, theˆnal concentration of FabD in the mixture was also similar to the following immunoprecipitation experiment. In contrast to the case of Fig. 5A , removal of FabD from the crude specimen did not signiˆcantly reduce its MAT activity.
The removal of FabD by immunoprecipitation was further assessed by Western blotting. Based on the results of concentration course experiments (Fig. 5A) , an excess of antibody (1 mg) was used against 1 mg of FabD in the crude enzyme preparation. Figure 6 shows the Western blot proˆle of crude enzyme treated with the anti-FabD. Consistent with the foregoing observation, only a single band was present in the crude B. subtilis enzyme (lane 1). Treatment of the crude enzyme with non-immunized control IgG had essentially no eŠect on the intensity of the FabD band (lane 2). However, treatment with anti-FabD IgG signiˆcantly decreased the band intensity almost to the blank level (compare lanes 3, and 5). As shown in Fig. 6 , the background level of the faint band was also detected in the antibody itself at the molecular size of FabD (lanes 4 and 5) . Densitometric analysis of the band intensity and subtraction of the background level revealed that the crude enzyme contained a trace of FabD protein. The immunoreactive bands of 44 k and 68 k both originated in the IgG (lanes 4 and 5) .
The crude FAS retained more than 80z of its original activity even after removal of FabD protein by centrifugation, suggesting the presence of another enzyme source for FabD (Fig. 5B) . We therefore attempted to identify another MAT source in the crude FAS of B. subtilis, and examined the concentration of FabD and MAT activity in the enzyme fractions separated on Mono Q column. The highest concentration of FabD was noted around fraction 25, while the highest MAT speciˆc activity was seen with the fractions of 20 or 21 (Fig. 7) . The MAT activity thus did not necessarily correlate with the concentration of FabD in the enzyme fractions, supporting the view that there was an another enzyme source of MAT activity in the cell homogenate of B. subtilis. This is particularly true for the fraction 19 which lacked FabD and showed relatively higher speciˆc activity. The gel-ˆltration chromatography of the combined specimens of fraction 19 and 20 found that the molecular mass for the alternate MAT activity was 58 kDa. EŠects of immunoprecipitation on the in vitro BCFA biosynthesis were studied with several precursors. BCFAs are synthesized from branched-chain aketo acids (BCKAs) of valine, leucine, and isoleucine as the primer source: a-ketoisovalerate (KIV), aketoisocaproate (KIC), and a-keto-b-methylvalerate (KMV). 14) These BCKAs are successively decarboxylated either by BCKAs dehydrogenase to give a rise to branched-chain acyl-CoAs (BCACs): isobutyrylCoA from KIV, isovaleryl-CoA from KIC, and a(2)-methylbutyryl-CoA from KMV, or possibly by BCKAs decarboxylase to give rise to the corresponding aldehyde derivatives. 3, 15) Although the crude FAS accepts both BCKAs and BCACs for in vitro BCFA biosynthesis, the latter seemed to be a better substrate for the current purpose because these precursors directly react with malonyl-ACP, the reaction product of FabD, to produce fatty acids. As KMV among the BCKAs was the best precursor for crude FAS, 15) this precursor was also included as the primer in this experiment.
Removal of FabD by immunoprecipitation lowered the incorporation of [
14 C]-malonyl-CoA into fatty acid 50 to 60z of control (none), but did not completely diminish the BCFA biosynthesis from BCAC primers ( Table 2 ). In the case of [
14 C]-KMV as a precursor, the treatment lowered the activity only to 80z. Thus the removal of FabD from the crude synthetase system did not necessarily eliminate the BCFA biosynthesis from both BCKA and BCAC primers. Addition of the pre-immune serum IgG slightly elevated the level of fatty acid biosynthesis from BCACs, but not from KMV.
We observed an anti-FabD reactive band in the crude FAS of B. insolitus as seen in Fig. 4 . However, no precipitation line between anti-FabD and the crude FAS of B. insolitus was formed on double immunodiŠusion analysis. For this reason, no immunoprecipitation experiment was done with the crude FAS of B. insolitus.
Discussion
Theˆnding that FabD was not essential for the assay of the partially puriˆed condensing enzyme from B. insolitus prompted us to study the necessity of FabD in the BCFA biosynthesis. This observation may simply be interpreted as that the partially puried KAS contained contaminant FabD. However, the increase in the speciˆc activity of KAS with the progress of puriˆcation may argue against this explanation. The puriˆcation procedure usually decreases the contaminant concentration in the specimens. Thus, if FabD is essential for the condensing reaction, one can expect that the speciˆc activity of KAS assayed without addition of FabD should be lowered by the puriˆcation. However, the puriˆcation of KAS increased the speciˆc activity to 5-fold, which may suggest its independence of this enzyme on FabD reaction. This may in turn suggest that KAS of Bacilli itself has the intrinsic MAT activity.
It has been proposed that the B. subtilis KAS III homolog fabHA (yjaX) or fabHB (yhfB) is a deciding factor for the preference of bulky BCACs as primers of BCFA biosynthesis. His-tag fusion protein of these gene products preferentially accepted iso-and anteiso-BCAC primers as substrates rather than acetyl-CoA, which is the starter unit for the SCFA biosynthesis.
5) The nature of the condensing enzyme from Bacilli seemed to diŠer from that for SCFA biosynthesis. This explanation may further be supported by their resistance to the antibiotic thiolactomycin, which selectively inhibits dissociated Type II, but not Type I, FAS. 16) Thus the studies on KAS entities in Bacilli may unveil the novel and unique features of this enzyme, and may address the questions raised by this study.
We hereinˆrst demonstrated that the FabD protein is not essential for in vitro BCFA biosynthesis by the crude FASs of B. subtilis. We applied the immunoprecipitation method to remove FabD protein from the crude BCFA synthetase. The antibody prepared in this study speciˆcally recognized the FabD protein in the crude FAS (Figs. 4 and 6) , and was found to be eŠective to remove FabD protein from the crude system. By use of a similar method, our previous study has demonstrated the requirement of BCKA decarboxylase for the BCFA biosynthesis, and conˆrmed the usefulness of the immunoprecipitation method. 15) The supernatant after immunoprecipitation in this study thus speciˆcally lacked FabD protein retaining with activities of all other members of FASs. However, the removal of FabD did not necessarily eliminate the in vitro BCFA biosynthetic activity from the crude FAS, but only reduced the level to 50-60z for the case of BCACs, and to 80z for KMV primer. Thisˆnding clearly indicates that the FabD in the crude system is not essential for the BCFA biosynthesis.
The point to mention is that there may be an alternate enzyme source that can catalyze the MAT reaction. We attempted to identify another enzyme source in the crude FAS, and detected alternate MAT activity apart from FabD protein (Fig. 7) . Thus, the observation that the removal of FabD from the crude FAS did not eliminate the MAT activity in the crude enzyme may be explained by the presence of another enzyme source for FabD. A search of the B. subtilis genome database found three MAT homologues described as involved in polyketide synthesis: PksC, PksE, and PksD with the similarity of 56, 54, and 40z to FabD, respectively. The polyketide synthase (PKS) and FAS are related not only in their mechanism of carbon chain extension but also in their primary sequences. It thus appeared hold true that these two systems evolved from a common origin after early gene duplication. As the many biochemical steps of FAS and PKS are similar, it seems quite reasonable that these two system share common enzymatic activities up to the point at which the pathways diverge. In this context, it is noteworthy that FabD has been implicated as functioning to charge the ACP subunit of FAS and PKS prior to the condensation reaction. 17) Thus the gene product of MAT homologues in the crude extract may be a potential alternate enzyme source, and may compensate the deˆciency of the FabD activity for BCFA biosynthesis.
The independence of BCFA biosynthesis on FabD protein may alternatively agree in part with the previous observation that the reconstituted polyketide synthase (PKS) from Streptomyces coelicolor produced polyketides without MAT when holo ACP is present in excess. The polyketides are synthesized by a similar mechanism that resembles fatty acid biosynthesis. In that case, the PKS-ACP catalyses selfmalonylation, and provides malonyl-ACP for the successive condensing reaction. [18] [19] [20] As is the case of PKS, it also may be possible that the ACP of B. subtilis undergoes selfmalonylation, and may serve as a chain extension unit of fatty acid biosynthesis. To address this question, we studied the selfmalonylation of B. subtilis ACP under the same conditions as the MAT assay, but in the absence of a MAT enzyme source. The puriˆed B. subtilis ACP alone, however, showed no selfmalonylation in this study (data not shown), and this may negate the possibility above that the ACP selfmalonylation was responsible for the FabD independent BCFA biosynthesis.
Although this studyˆrst demonstrated that BCFA biosynthesis by crude FAS did not necessarily require FabD protein, the current in vitro results should be reasonably related to in vivo experiments. One experimental approach for this purpose is to study BCFA biosynthesis in an FabD-deˆcient mutant. The FabD-deˆcient mutant of E. coli was an auxotroph requiring both saturated and unsaturated fatty acid.
